On August 4, Astera Labs, Inc. rose 4.17% in pre-market trading, trading at $334.55 per share, with turnover of $2.488 million.

On the news front, Morgan Stanley significantly raised its price target on the company from $240 to $335 while maintaining an Overweight rating, citing the company's strong positioning in AI infrastructure growth. Additionally, the company is scheduled to report second-quarter earnings after today's close, with consensus EPS estimates at $0.42, prompting funds to position ahead of the release.

Notably, Barclays had previously raised its target price from $200 to $325, reflecting broad institutional consensus on the high-speed connectivity chip sector driven by AI compute expansion. The stock declined 5.85% in the prior session amid broader semiconductor sector weakness, making the current pre-market rebound a confluence of oversold recovery and multiple positive catalysts.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)